Shilpa Pharma Lifesciences’ Unit II, Raichur, Karnataka clears PMDA Japan, GMP inspection
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Meningitis still affects more than 2.5 million people globally each year
Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
The approval bolsters the company's Mycophenolate Mofetil portfolio
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Hospital joins with Intuitive to install da Vinci systems to support enhanced healthcare delivery and patient outcomes across India
Subscribe To Our Newsletter & Stay Updated